Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Ciba-Geigy advances wound-healing agent into phase II

Sep. 27, 1996

Amgen claims wound-healing growth factor

Sep. 20, 1996

Hair loss product to enter pivotal trials in Europe

Sep. 20, 1996

Novel antiproliferative agents from RDF

Sep. 20, 1996

Seratrodast claimed for the treatment of atopic dermatitis

Sep. 13, 1996

Allergan discloses compounds with retinoid-like activity

Sep. 13, 1996

Liarozole claimed for inhibiting calcitriol metabolism

Sep. 13, 1996

Retinoid compounds for dermatological disorders

Sep. 13, 1996

Allergen describes compounds with retinoid-like activity

Sep. 6, 1996

Interferon gamma-1b enters pivotal trials for atopic dermatitis

Sep. 6, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...